Immunotherapy in prostate cancer: new horizon of hurdles and hopes

PURPOSE: Prostate cancer (PCa) is the most common malignancy in men and the cause for the second most common cancer-related death in the western world. Despite ongoing development of novel approaches such as second generation androgen receptor targeted therapies, metastatic disease is still fatal. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsaur, Igor, Brandt, Maximilian P., Juengel, Eva, Manceau, Cécile, Ploussard, Guillaume
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Topic Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514362/
https://www.ncbi.nlm.nih.gov/pubmed/33106940
http://dx.doi.org/10.1007/s00345-020-03497-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514362/
https://www.ncbi.nlm.nih.gov/pubmed/33106940
http://dx.doi.org/10.1007/s00345-020-03497-1

Ejemplares similares